# Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

> **NCT05135286** · PHASE3 · COMPLETED · sponsor: **Visus Therapeutics** · enrollment: 629 (actual)

## Conditions studied

- Presbyopia

## Interventions

- **DRUG:** BRIMOCHOL™ PF
- **DRUG:** Carbachol PF
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT05135286
- **Lead sponsor:** Visus Therapeutics
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-15
- **Primary completion:** 2025-03-13
- **Final completion:** 2025-03-13
- **Target enrollment:** 629 (ACTUAL)
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05135286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05135286, "Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05135286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*